NTWK vs VRTX · P/E 30, rev $73.1M vs P/E 30, rev $3.33B
NetSol Technologies Inc (NTWK) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
NetSol Technologies Inc (NTWK) is a software - application company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported NTWK revenue for 2025-06-30 was $73.1M. Net income was $4.6M. NTWK currently screens at market cap $53.2M and trailing P/E 29.9.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
NTWK currently screens at market cap $53.2M and trailing P/E 29.9. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the NTWK and VRTX stock pages for the full models.
Not investment advice.